TMED vs. CNCR
TMED (T. Rowe Price Health Care ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds. TMED charges 0.44%/yr vs 0.79%/yr for CNCR.
Performance
TMED vs. CNCR - Performance Comparison
Loading charts...
Returns By Period
TMED
- 1D
- 1.71%
- 1M
- 5.92%
- YTD
- 10.47%
- 6M
- 9.58%
- 1Y
- 33.64%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CNCR
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
TMED vs. CNCR - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
TMED T. Rowe Price Health Care ETF | 13.64% |
CNCR Loncar Cancer Immunotherapy ETF | 0.00% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TMED vs. CNCR — Risk / Return Rank
TMED
CNCR
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
TMED vs. CNCR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TMED | CNCR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.32 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 3.04 | — | — |
| Martin ratioReturn relative to average drawdown | 9.95 | — | — |
Loading charts...
Drawdowns
TMED vs. CNCR - Drawdown Comparison
The maximum TMED drawdown since its inception was -11.11%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for TMED and CNCR.
Loading charts...
Drawdown Indicators
| TMED | CNCR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -11.11% | 0.00% | -11.11% |
Max Drawdown (1Y)Largest decline over 1 year | -11.11% | — | — |
Current DrawdownCurrent decline from peak | 0.00% | 0.00% | 0.00% |
Average DrawdownAverage peak-to-trough decline | -2.47% | 0.00% | -2.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.39% | — | — |
Volatility
TMED vs. CNCR - Volatility Comparison
Loading charts...
Volatility by Period
| TMED | CNCR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.00% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 13.61% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 18.21% | 0.00% | +18.21% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.08% | 0.00% | +18.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.08% | 0.00% | +18.08% |
TMED vs. CNCR - Expense Ratio Comparison
TMED has a 0.44% expense ratio, which is lower than CNCR's 0.79% expense ratio.
Dividends
TMED vs. CNCR - Dividend Comparison
TMED's dividend yield for the trailing twelve months is around 0.49%, while CNCR has not paid dividends to shareholders.
| Position | TTM | 2025 |
|---|---|---|
CNCR Loncar Cancer Immunotherapy ETF | 0.00% | 0.00% |
TMED T. Rowe Price Health Care ETF | 0.49% | 0.54% |
Frequently Asked Questions
On fees, TMED is cheaper at 0.44% per year. The better choice depends on whether you care most about return, fees, risk, or income.
TMED is cheaper with a 0.44% expense ratio, compared with 0.79% for CNCR.
TMED has the higher dividend yield at 0.49%, compared with 0.00% for CNCR.
They also come from different issuers: T. Rowe Price and Exchange Traded Concepts. Their fees differ too: 0.44% for TMED and 0.79% for CNCR.
Find the right allocation for TMED and CNCR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer